HIAL
PFE icon

Highland Investment Advisors LLC’s Pfizer PFE Stock Holding History

Highland Investment Advisors LLC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5K Buy
+645
New +$16.9K 0.01% 308

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Highland Investment Advisors LLC's PFE Position: Q2 2026 in Review

Highland Investment Advisors LLC opened a new position in Pfizer (PFE) in Q2 2026: 645 shares worth $15.5K. The stake represents 0.01% of the portfolio and ranks #308 among its holdings.

2,429 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Highland Investment Advisors LLC held 645 shares of Pfizer worth $15.5K as of Q2 2026.
  • Pfizer was a new Highland Investment Advisors LLC position in Q2 2026.
  • Pfizer made up 0.01% of Highland Investment Advisors LLC's portfolio in Q2 2026, its #308 holding.
  • 2,429 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Highland Investment Advisors LLC's 13F filing for Q2 2026, filed 13 Aug 2026.